Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引：0

作者：

Tack, J. ^{[1
]}

Louis, E. ^{[2
,3
]}

Persy, V. ^{[4
]}

Urbain, D. ^{[5
]}

机构：

[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium

[2] CHU, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Hugin Mugin Res, Antwerp, Belgium

[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2013年 / 76卷 / 04期

关键词：

Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.

引用

页码：393 / 402

页数：10

共 50 条

[41] An evaluation of the use of proton pump inhibitors
Walker, NM
McDonald, J
PHARMACY WORLD & SCIENCE, 2001, 23 (03): : 116 - 117
[42] An evaluation of the use of proton pump inhibitors
N.M. Walker
J. McDonald
Pharmacy World and Science, 2001, 23 : 116 - 117
[43] Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review
Del-Pino, Miguel
Sanz, Emilio J.
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2023, 24
[44] Prescribing patterns of proton pump inhibitors in patients with NSAID use - a comparison between switzerland and the UK in primary care
Bietry, Fabienne A. M.
Reich, Oliver
Jick, Susan S.
Meier, Christoph R.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 128 - 129
[45] Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area
Martinez Gorostiaga, Javier
Echevarria Orella, Enrique
Calvo Hernaez, Begona
REVISTA ESPANOLA DE SALUD PUBLICA, 2018, 92
[46] Peptic ulcer disease in the era of proton pump inhibitors - a population analysis
Chalasani, S.
Rogers, A.
Winters, D. C.
BRITISH JOURNAL OF SURGERY, 2015, 102 : 32 - 32
[47] INTERVENTION TO IMPROVE THE APPROPRIATE PROTON PUMP INHIBITOR USE IN PRIMARY CARE
Bonet, S.
Oms, M.
Pedraza, A.
Rodriguez, G.
Balanzo, M.
Ferro, J. J.
Rosic, I
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 9 - 10
[48] Are higher doses of proton pump inhibitors better in acute peptic bleeding?
Villalon, Alejandro
Olmos, Roberto
Rada, Gabriel
MEDWAVE, 2016, 16 : e6476
[49] Proton Pump Inhibitors After Endoscopy in Peptic Ulcer Bleeding Response
Andriulli, Angelo
Marmo, Riccardo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (06): : 1595 - 1596
[50] Introduction of proton pump inhibitors - Consequences for surgical treatment of peptic ulcer
Tonus, C
Weisenfeld, E
Appel, P
Nier, H
HEPATO-GASTROENTEROLOGY, 2000, 47 (31) : 285 - 290

← 1 2 3 4 5 →